Walleye Capital LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$2,750,000
-2.3%
5,000,0000.0%0.05%
-7.4%
Q3 2022$2,816,000
+1.7%
5,000,0000.0%0.05%
-28.9%
Q2 2022$2,769,000
+7.4%
5,000,000
+99900.0%
0.08%
+10.1%
Q1 2022$2,578,000
-2.3%
5,0000.0%0.07%
-15.9%
Q4 2021$2,638,0005,0000.08%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 41,029,000$29,8338.94%
Two Seas Capital LP 17,275,000$9,358,1271.88%
DCF Advisers, LLC 3,050,000$1,586,0000.86%
Context Capital Management, LLC 17,851$9,2980.75%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 22,250,000$11,570,0000.48%
SILVERBACK ASSET MANAGEMENT LLC 6,500,000$3,412,5000.47%
Saltoro Capital, LP 1,000,000$520,0000.47%
WHITEBOX ADVISORS LLC 16,850,000$8,677,7500.28%
TENOR CAPITAL MANAGEMENT Co., L.P. 19,000,000$10,545,0000.23%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 31,100,000$16,016,5000.21%
View complete list of ESPERION THERAPEUTICS INC NE shareholders